Vitrafy Life Sciences (ASX:VFY) Scaled Net Operating Assets: -0.03 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:VFY Vitrafy Life Sciences Ltd ASX:VFY
5 GF Score
Price A$2.81
! 5 Warning Signs
View Full Analysis

What is Vitrafy Life Sciences Scaled Net Operating Assets?

Vitrafy Life Sciences ASX:VFY -0.71% 5 Scaled Net Operating Assets is -0.03 as of Dec. 2025. GuruFocus rates ASX:VFY with a GF Score™ of 5/100. The stock has 5 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vitrafy Life Sciences's operating assets for the quarter that ended in Dec. 2025 was A$0.88 Mil. Vitrafy Life Sciences's operating liabilities for the quarter that ended in Dec. 2025 was A$1.68 Mil. Vitrafy Life Sciences's Total Assets for the quarter that ended in Jun. 2025 was A$31.84 Mil. Therefore, Vitrafy Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was -0.03.


Vitrafy Life Sciences Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Vitrafy Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrafy Life Sciences Scaled Net Operating Assets Chart

Vitrafy Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Scaled Net Operating Assets
0.00 0.00 0.00 -0.01

Vitrafy Life Sciences Semi-Annual Data
Jun22 Jun23 Jun24 Dec24 Jun25 Dec25
Scaled Net Operating Assets Get a 7-Day Free Trial 0.00 0.00 0.02 -0.01 -0.03

ASX:VFY vs MSFT, ORCL, PLTR: Scaled Net Operating Assets Comparison

For the Software - Infrastructure subindustry, Vitrafy Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrafy Life Sciences Scaled Net Operating Assets vs Software Industry

For the Software industry and Technology sector, Vitrafy Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Vitrafy Life Sciences's Scaled Net Operating Assets falls into.


ASX:VFY
5GF Score
Vitrafy Life Sciences Ltd ASX:VFY
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrafy Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Vitrafy Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2025 )
=(Operating Assets (A: Jun. 2025 )-Operating Liabilities (A: Jun. 2025 ))/Total Assets (A: Jun. 2024 )
=(2.249-2.683)/41.332
=-0.01

where

Operating Assets(A: Jun. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=31.844 - 29.595
=2.249

Operating Liabilities(A: Jun. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.076 - 0.303 - 0.09
=2.683

Vitrafy Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2025 )
=(Operating Assets (Q: Dec. 2025 )-Operating Liabilities (Q: Dec. 2025 ))/Total Assets (Q: Jun. 2025 )
=(0.883-1.682)/31.844
=-0.03

where

Operating Assets(Q: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=23.682 - 22.799
=0.883

Operating Liabilities(Q: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.031 - 0.255 - 0.094
=1.682

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.03 mean?
Vitrafy Life Sciences (ASX:VFY) has a Scaled Net Operating Assets of -0.03 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Vitrafy Life Sciences and its competitors.
Is Vitrafy Life Sciences' Scaled Net Operating Assets too high?
Vitrafy Life Sciences' current Scaled Net Operating Assets is -0.03. Overall, Vitrafy Life Sciences has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Vitrafy Life Sciences' Scaled Net Operating Assets compare to MSFT and ORCL?
Vitrafy Life Sciences' Scaled Net Operating Assets of -0.03 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Software company?
A good Scaled Net Operating Assets depends on the Software industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Vitrafy Life Sciences and its competitors. Vitrafy Life Sciences's current Scaled Net Operating Assets is -0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrafy Life Sciences stock overvalued right now?
Vitrafy Life Sciences (ASX:VFY) has a current Scaled Net Operating Assets of -0.03. The current Scaled Net Operating Assets is -0.03. Vitrafy Life Sciences' overall GF Score™ is 5/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Vitrafy Life Sciences (ASX:VFY), the current Scaled Net Operating Assets is -0.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitrafy Life Sciences Business Description

Address 385 Bourke Street, Suite 2, Level 11, Melbourne, VIC, AUS, 3000
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy's Smart Cryopreservation Device; Vitrafy's Smart Thawing Device and Vitrafy's Smart Packaging.
5GF Score

Get the complete analysis for ASX:VFY

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.81
Price